Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Ryanair Holdings plc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Ryanair Holdings plc trades at $51.7 (market cap $25.64B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Ryanair Holdings plc pays the higher dividend (1.75%). Which is the better fit depends on your goals.
| GEHC | RYAAY | |
|---|---|---|
Market Cap | $30.93B | $25.64B |
Volume | 5,033,451 | 2,272,403 |
Sector | Health | Industrials |
52-Week High | $88.16 | $73.82 |
52-Week Low | $59.48 | $51.33 |
Enterprise Value | $39.39B | $22.70B |
Dividend Yield | 0.23% | 1.75% |
Typical Hold Time | — | 72 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Ryanair Holdings (RYAAY) trades at $52.84, down 0.3% on the day, with a bearish technical signal despite attractive valuation metrics including a P/E of 12.86 and EV/EBITDA of 5.68. The company reported mixed Q2 2026 earnings with a slight miss on EPS expectations but maintains strong profitability with 12.13% net margins. Recent news highlights CEO commentary on potential airfare increases due to high oil prices and Boeing MAX 10 certification delays.
RYAAY presents a compelling value opportunity with strong fundamentals and analyst support (64.7% buy ratings), though near-term headwinds include fuel cost volatility and operational challenges. The stock's current bearish technical positioning near support levels may offer entry points for long-term investors seeking exposure to Europe's leading low-cost carrier.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
